This study reveals that kaempferol suppresses colorectal cancer progression by dual targeting of glucose metabolism (reducing UDP-GlcNAc flux) and OGT activity, thereby diminishing O-GlcNAcylation of Hsp47. The gene discussed is SERPINH1; the disease is colorectal cancer.